DePuy Synthes launches CONCORDE LIFT expandable interbody implant in US
DePuy Synthes, a Johnson & Johnson company, is launching the CONCORDE LIFT expandable interbody device in the US.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Jul 18
DePuy Synthes, a Johnson & Johnson company, is launching the CONCORDE LIFT expandable interbody device in the US.
24 Jul 18
OrthoSpin, a portfolio company of The Trendlines Group, has completed an investment round of $3m for its smart,…
24 Jul 18
Viscogliosi Brothers has signed an agreement to acquire next generation bone morphogenetic protein (BMP) development program from Bioventus…
19 Jul 18
Zavation has received 510(k) clearance from the US Food and Drug Administration (FDA) to market Normandy VBR System…
17 Jul 18
NuVasive has introduced Reline MAS Midline (RMM), the next evolution of the Reline system that provides procedural versatility…
16 Jul 18
Aziyo Biologics, a fully integrated regenerative medicine company, has entered into a co-marketing agreement with SurGenTec, a privately-owned…
11 Jul 18
NuVasive will unveil its XLIF lordotic expandable (XLX) interbody system, which just received 510(k) clearance from the US…
09 Jul 18
Paragon 28 has introduced new cut guide system, which is designed to control bone resection while addressing IM…
04 Jul 18
US-based musculoskeletal solutions company Globus Medical has added two new solutions to its orthopedic trauma product portfolio.
19 Jun 18
OrthoGrid Systems has introduced new patent-protected HipGrid Nine system for outpatient total hip replacement.